{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:12:01Z","timestamp":1790885521622,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.lfs.2023.122349","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T02:18:59Z","timestamp":1702952339000},"page":"122349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1\/NLRP3 pathways"],"prefix":"10.1016","volume":"337","author":[{"given":"Yasmin A.","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal M.","family":"El-Gayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-3697","authenticated-orcid":false,"given":"Noha","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2023.122349_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1503","article-title":"Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression","volume":"10","author":"Ford","year":"2018","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/j.lfs.2023.122349_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular mechanisms of liver fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122349_bb0015","first-page":"4","article-title":"Alpha-smooth muscle actin (\u03b1-SMA)","author":"Cherng","year":"2008","journal-title":"J. Am. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11010-007-9629-9","article-title":"Effects of decorin on the expression of \u03b1-smooth muscle actin in a human myofibroblast cell line","volume":"308","author":"Nakatani","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"24","key":"10.1016\/j.lfs.2023.122349_bb0025","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122349_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40139-013-0018-7","article-title":"Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts","volume":"1","author":"Liu","year":"2013","journal-title":"Current Pathobiology Reports"},{"issue":"15","key":"10.1016\/j.lfs.2023.122349_bb0035","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0040","first-page":"C1055","article-title":"The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapies","volume":"318","author":"Ishay","year":"2020","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"7503","key":"10.1016\/j.lfs.2023.122349_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.lfs.2023.122349_bb0050","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis\u2014updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2023.122349_bb0055","first-page":"7","article-title":"Fibrosis and hepatic regeneration mechanism","author":"Zu\u00f1iga-Aguilar","year":"2020","journal-title":"Translational Gastroenterology and Hepatology"},{"key":"10.1016\/j.lfs.2023.122349_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/178910","article-title":"Sphingolipid metabolic pathway: an overview of major roles played in human diseases","volume":"2013","author":"Pralhada Rao","year":"2013","journal-title":"J Lipids"},{"issue":"7","key":"10.1016\/j.lfs.2023.122349_bb0065","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI97949","article-title":"Role of sphingolipids in senescence: implication in aging and age-related diseases","volume":"128","author":"Trayssac","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.lfs.2023.122349_bb0070","first-page":"484","article-title":"Ceramide and sphingosine-1-phosphate in cancer, two faces of the sphinx","volume":"4","author":"Espaillat","year":"2015","journal-title":"Transl. Cancer Res."},{"issue":"8","key":"10.1016\/j.lfs.2023.122349_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081898","article-title":"Targeting the sphingosine kinase\/sphingosine-1-phosphate signaling axis in drug discovery for cancer therapy","volume":"13","author":"Gupta","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1_Supplement","key":"10.1016\/j.lfs.2023.122349_bb0080","doi-asserted-by":"crossref","first-page":"178.11","DOI":"10.4049\/jimmunol.200.Supp.178.11","article-title":"Crosstalk of sphingolipids and inflammasomes modulates tumor microenvironment and promotes cancer progression","volume":"200","author":"Guo","year":"2018","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122349_bb0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201142079","article-title":"Sphingosine regulates the NLRP3-inflammasome and IL-1\u03b2 release from macrophages","volume":"42","author":"Luheshi","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","article-title":"Regulated cell death: discovery, features and implications for neurodegenerative diseases","volume":"19","author":"Cui","year":"2021","journal-title":"Cell Communication and Signaling"},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-021-01959-x","article-title":"Pyroptosis: a new paradigm of cell death for fighting against cancer","volume":"40","author":"Tan","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.lfs.2023.122349_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"10.1016\/j.lfs.2023.122349_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.lfs.2023.122349_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122349_bb0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JIR.S277457","article-title":"Role of caspase-1 in the pathogenesis of inflammatory-associated chronic noncommunicable diseases","volume":"13","author":"Molla","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.lfs.2023.122349_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13137","article-title":"Pyroptosis: a promising therapeutic target for noninfectious diseases","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.lfs.2023.122349_bb0125","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2147\/DDDT.S194787","article-title":"Salvianolic acid A attenuates CCl(4)-induced liver fibrosis by regulating the PI3K\/AKT\/mTOR, Bcl-2\/Bax and caspase-3\/cleaved caspase-3 signaling pathways","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"24","key":"10.1016\/j.lfs.2023.122349_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249682","article-title":"Cell death in liver diseases: a review","volume":"21","author":"Shojaie","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","article-title":"Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model","volume":"59","author":"Thapaliya","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2023.122349_bb0140","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1096\/fj.14-261289","article-title":"Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-\u03b3 that regulates neoangiogenesis","volume":"29","author":"Parham","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2023.122349_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.lfs.2023.122349_bb0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5223\/pghn.2020.23.4.346","article-title":"Peroxisome proliferator-activated receptor gamma agonist attenuates liver fibrosis by several fibrogenic pathways in an animal model of cholestatic fibrosis","volume":"23","author":"Alatas","year":"2020","journal-title":"Pediatric Gastroenterology, Hepatology & Nutrition"},{"issue":"5","key":"10.1016\/j.lfs.2023.122349_bb0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Skat-R\u00f8rdam","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3164\/jcbn.12-79","article-title":"Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis - a pilot study","volume":"53","author":"Risti\u0107-Medi\u0107","year":"2013","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11901-019-00462-4","article-title":"Novel targets and drug development in portal hypertension","volume":"18","author":"Schierwagen","year":"2019","journal-title":"Current Hepatology Reports"},{"key":"10.1016\/j.lfs.2023.122349_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12876-015-0248-8","article-title":"Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells","volume":"15","author":"Chong","year":"2015","journal-title":"BMC Gastroenterol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122349_bb0175","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.4049\/jimmunol.176.12.7657","article-title":"Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease","volume":"176","author":"Morimoto","year":"2006","journal-title":"The Journal of Immunology"},{"issue":"19","key":"10.1016\/j.lfs.2023.122349_bb0180","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1161\/01.CIR.0000142866.50300.EB","article-title":"Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells","volume":"110","author":"Spyridopoulos","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2023.122349_bb0185","first-page":"2450","article-title":"Sphingosine kinase inhibitors: a patent review","volume":"41","author":"Cao","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.lfs.2023.122349_bb0190","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/ptr.7104","article-title":"Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2023.122349_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112314","article-title":"Quercetin and non-alcoholic fatty liver disease: a review based on experimental data and bioinformatic analysis","volume":"154","author":"Chen","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2023.122349_bb0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fphar.2018.00072","article-title":"The flavonoid quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in mice","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122349_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116933","article-title":"Beyond its antioxidant properties: quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats","volume":"236","author":"Salama","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2023.122349_bb0210","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00063.2016","article-title":"Statins improve NASH via inhibition of RhoA and Ras","volume":"311","author":"Schierwagen","year":"2016","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.lfs.2023.122349_bb0215","series-title":"Fibrosis Research: Methods and Protocols","first-page":"237","article-title":"Modeling liver fibrosis in rodents","author":"Constandinou","year":"2005"},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0220","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.3892\/mmr.2016.5178","article-title":"Simvastatin ameliorates ventricular remodeling via the TGF-\u03b21 signaling pathway in rats following myocardial infarction","volume":"13","author":"Xiao","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0225","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/fcp.12315","article-title":"Quercetin reverses experimental cirrhosis by immunomodulation of the proinflammatory and profibrotic processes","volume":"31","author":"Casas-Grajales","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0235","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122349_bb0255","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/ijms21113796","article-title":"Liver fibrosis and inflammation under the control of ERK2","volume":"21","author":"Jeng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.lfs.2023.122349_bb0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1254\/jphs.CRJ04003X","article-title":"Anti-inflammatory plant flavonoids and cellular action mechanisms","volume":"96","author":"Kim","year":"2004","journal-title":"J. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2023.122349_bb0270","article-title":"Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2023.122349_bb0275","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12013-013-9698-1","article-title":"The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis","volume":"68","author":"Motawi","year":"2014","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0280","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2018.02.067","article-title":"Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis","volume":"497","author":"Jang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.lfs.2023.122349_bb0285","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/ptr.7569","article-title":"The construction of preclinical evidence for the treatment of liver fibrosis with quercetin: a systematic review and meta-analysis","volume":"36","author":"Guo","year":"2022","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.122349_bb0295","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.29885","article-title":"Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2","volume":"68","author":"Lan","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/srep32119","article-title":"Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122349_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110586","article-title":"Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1","volume":"130","author":"Lan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.lfs.2023.122349_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213916","article-title":"Effect of quercetin and fingolimod, alone or in combination, on the sphingolipid metabolism in HepG2 cells","volume":"23","author":"Momchilova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0320","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1139\/bcb-2017-0302","article-title":"Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1\/S1P signaling","volume":"96","author":"Zhang","year":"2018","journal-title":"Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55199-3","article-title":"Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: towards targeted anticancer therapy","volume":"9","author":"Gupta","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122349_bb0330","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9247285","article-title":"Sphingosine kinase 1 plays an important role in atorvastatin-mediated anti-inflammatory effect against acute lung injury","volume":"2021","author":"Wu","year":"2021","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.lfs.2023.122349_bb0335","article-title":"The relationship of sphingosine kinase 1 with pyroptosis provides a new strategy for tumor therapy","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.122349_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01149","article-title":"Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2023.122349_bb0345","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biocel.2010.01.008","article-title":"Nlrp3: an immune sensor of cellular stress and infection","volume":"42","author":"Lamkanfi","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0350","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.29523","article-title":"NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice","volume":"67","author":"Wree","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0355","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41419-021-03389-1","article-title":"Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.lfs.2023.122349_bb0360","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.5114\/aoms\/141155","article-title":"Statins as anti-pyroptotic agents","volume":"17","author":"Khalifeh","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2023.122349_bb0365","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1002\/jcp.30351","article-title":"Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of pyroptosis and neuroinflammation","volume":"236","author":"Chen","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122349_bb0370","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","article-title":"Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis","volume":"148","author":"Chipuk","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2023.122349_bb0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14744\/hf.2023.2023.0026","article-title":"Protective\/preventive effects of quercetin against cyclophosphamide-induced hepatic inflammation, apoptosis and fibrosis in rats","volume":"4","author":"Turedi","year":"2023","journal-title":"Hepatol Forum"},{"key":"10.1016\/j.lfs.2023.122349_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111494","article-title":"Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: comprehensive study","volume":"139","author":"Abo-Zalam","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.122349_bb0385","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2147\/DDDT.S310163","article-title":"The agonists of peroxisome proliferator-activated receptor-\u03b3 for liver fibrosis","volume":"15","author":"Li","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"issue":"15","key":"10.1016\/j.lfs.2023.122349_bb0390","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.3390\/ijms22158298","article-title":"PPARs as metabolic sensors and therapeutic targets in liver diseases","volume":"22","author":"Monroy-Ramirez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15171\/apb.2019.003","article-title":"Crosstalk between peroxisome proliferator-activated receptors and toll-like receptors: a systematic review","volume":"9","author":"Dana","year":"2019","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0400","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1499-3872(11)60009-X","article-title":"Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"28","key":"10.1016\/j.lfs.2023.122349_bb0405","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review","volume":"19","author":"S\u00e1nchez-Valle","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0410","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/j.2040-4603.2022.tb00210.x","article-title":"Oxidative stress and redox signaling in the pathophysiology of liver diseases","volume":"12","author":"Mooli","year":"2022","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2023.122349_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122349_bb0420","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.122349_bb0425","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3389\/fphar.2018.01428","article-title":"The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122349_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122772","article-title":"Nrf2, the master regulator of anti-oxidative responses","volume":"18","author":"Vomund","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122349_bb0435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"10.1016\/j.lfs.2023.122349_bb0440","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409001094","article-title":"The Nrf2-ARE cytoprotective pathway in astrocytes","volume":"11","author":"Vargas","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.lfs.2023.122349_bb0445","article-title":"The Nrf2 pathway in liver diseases","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:14:18Z","timestamp":1758402858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523009840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":86,"alternative-id":["S0024320523009840"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122349","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1\/NLRP3 pathways","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122349"}}